Insulet | PODD - Credores Comerciais

Preço das Ações
151.28
Mudança Diária
-16.25 -9.70%
Mensal
-25.28%
Anual
-42.76%
Q2 Previsão
171.40




Credores Comerciais Alterar Data
Abbott USD 4.24B 117M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
AtriCure USD 70.06M 8.34M 2026-03
Avanos Medical USD 52.3M 3.2M 2026-03
Baxter International USD 1.09B 87M 2026-03
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Boston Scientific USD 1.14B 3M 2026-03
Cardinal Health USD 37.83B 1.16B 2026-03
Cooper Companies USD 225.8M 74.6M 2025-12
Dexcom USD 1.94B 109.1M 2026-03
Edwards Lifesciences USD 181.1M 46.4M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Globus Medical USD 98.85M 11.62M 2025-12
ICU Medical USD 154.37M 17.38M 2025-12
Inogen USD 21.22M 684K 2025-09
Insulet USD 149.8M 74.8M 2026-03
Integra LifeSciences USD 87.95M 7.78M 2026-03
J&J USD 10.46B 1.53B 2026-03
Masimo USD 103M 14.9M 2025-12
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 67.85M 7.3M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Solventum Corp USD 699M 12M 2026-03
Stryker USD 1.8B 301M 2025-12
Tandem Diabetes Care USD 47.07M 414K 2025-12
Teleflex USD 130.2M 35.71M 2025-12
West Pharmaceutical Services USD 252.3M 1.4M 2026-03
Zimmer Biomet Holdings USD 361.2M 58.2M 2026-03